Sunil Vitthalrao Jagtap1 , Vaidehi Dharmesh Nagar2 , Shubham Sunil Jagtap3 , Shefali Mishra4
Ridolfi et al. in 1977 defined medullary breast carcinoma (MBC) as one of the invasive and malignant subtypes of breast cancer.1 It is a rare breast malignancy accounting for 5 % of breast carcinomas.2 Although MBC is considered as having good prognosis, patients reported as triple-negative breast cancers are associated with aggressive clinical behaviour and poor prognosis.3 Also factors like local invasion, evidence of regional metastasis, etc. will determine the progress of this type of cancer.
